Effects of TNF-Alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
Phase of Trial: Phase II
Latest Information Update: 26 May 2016
At a glance
- Drugs Etanercept (Primary)
- Indications Psoriasis
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 03 Apr 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 25 Jun 2013 Planned end date changed from 1 Dec 2015 to 1 Dec 2014 as reported by ClinicalTrials.gov.